Skip to main content
. 2022 May;43(5):682–688. doi: 10.3174/ajnr.A7477

FIG 5.

FIG 5.

IHC staining for a nonenhancing region of predicted hypercellularity outside of contrast enhancement (a 64-year-old man diagnosed with GBM). The ROI corresponds to an actual region of hypercellularity seen on H&E staining as well as portions of high MIB-1 index and CD31 positivity. These molecular features indicate that this CPM-identified region contains active, proliferating tumor beyond the contrast-enhancing region. CPM indicates cellularity prediction map.